Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford BioMedica acquires anticancer macrophage technology

May 2, 1997

Emisphere receives notices of allowance for oral delivery technologies

April 28, 1997

LifeCell issued U.S. patent for ThromboSol blood platelet preservation product

April 28, 1997

Biosource awarded grant for human therapeutic protein production

April 25, 1997

Avigen granted patent on high-yield AAV production for gene therapy

April 24, 1997

Hybridon issued patent for pent-enoyl-protected nucleotides

April 23, 1997

Oncor's Sunrise Amplification Detection System presented

April 23, 1997

Genetronics develops electroporation therapy drug delivery system

April 23, 1997

AntiCancer receives grant for development of mouse cancer model

April 21, 1997

Ribozyme and Schering AG to collaborate on target validation and therapeutic development

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...